Review Time
Beximco Pharmaceuticals Ltd. (Beximco Pharma) has undoubtedly carved out a strong position as one of Bangladesh’s leading pharmaceutical companies, and its growing global footprint makes it even more impressive. The company stands out for its continuous commitment to innovation, research, and affordable healthcare solutions. Over the years, Beximco has expanded its operations across many international markets, exporting medicines to more than 50 countries, including highly regulated ones in the US and Europe. This achievement not only boosts Bangladesh’s reputation in the pharmaceutical industry but also reflects Beximco’s focus on quality and compliance with global standards.
One of the most admirable aspects of Beximco is its emphasis on cutting-edge technology and world-class manufacturing facilities, which have allowed it to introduce advanced therapies and generics at competitive prices. The company has also contributed significantly to making essential drugs more accessible, both domestically and abroad.
Claim your business profile now and gain access to all features and respond to customer reviews.
Beximco Pharmaceuticals Ltd. (Beximco Pharma) is one of the leading pharmaceutical companies in Bangladesh, recognized for its innovation, quality, and global reach. Established in 1976, the company has evolved into a major player in both domestic and international markets, producing a wide range of generic medicines covering diverse therapeutic areas such as cardiology, respiratory, gastroenterology, oncology, dermatology, and neurology. Its state-of-the-art manufacturing facilities are certified by regulatory authorities including the US FDA, EMA, TGA Australia, Health Canada, and others, enabling exports to more than 50 countries worldwide, including highly regulated markets like the USA and Europe.
Beximco Pharma was the first Bangladeshi company to export medicine to the US market, marking a significant milestone for the country’s pharmaceutical industry. The company has pioneered affordable treatment options, producing high-quality generics and lifesaving drugs, including specialized inhalers, suppositories, lyophilized injectables, and biologics. During global health crises, it gained international attention by launching remdesivir and molnupiravir for COVID-19 treatment as the first generic versions in the world.
